AN1
Click for more information
0.00% 0.8¢ anagenics limited

Lyramid Ltd and KineraLtd would themselves commercialise their...

  1. siren4
    1,436 Posts.
    lightbulb Created with Sketch. 141
    clock Created with Sketch.
    29/11/16
    09:34
    Post #: 20952395
    Lyramid Ltd and KineraLtd would themselves commercialise their IP including Advangen paying either as applicable for its Midkine for its Evolis range. The present "lifeline" would not be severed. Any other funding if required would be on commercial terms. However, the subsidiaries were never meant to bleed Cellmid. Good point Hobbit2233 I hope I've answered.
    CDY Price at posting: 2.9¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

PV1 Provaris updates on progress with Uniper under hydrogen MOU – not long after interesting ASX response
right-arrow Created with Sketch.
GBR Great Boulder hits fresh gold finds to the north of Mulga Bill in Meekatharra, WA
right-arrow Created with Sketch.
WGX Mining start at South Junction adds to Westgold's hopes for WA gold complex
right-arrow Created with Sketch.
TPG ACCC says no issue with TPG Telecom and Optus Mobile sharing regional networks; spectrum
right-arrow Created with Sketch.
GED Golden Deeps sniffs 80-metre-long copper and zinc sulphide zone at NSW's Havilah
right-arrow Created with Sketch.
EBR EBR Systems’ heart pacing device on-target to reach the US market
right-arrow Created with Sketch.
watchlist Created with Sketch. Add AN1 (ASX) to my watchlist
(20min delay)
Last
0.8¢ 		Change
0.000(0.00%) 		Mkt cap ! $3.690M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0
AN1 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.